[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100601955":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":37,"locations":43,"responsibleParty":58,"collaborators":10,"id":60,"slug":10,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":61,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":73,"studyType":74,"phases":10,"briefSummary":75,"conditions":76,"keywords":84,"overallStatus":45,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Peking University Third Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"model-stratified group",null,"Patient receiving treatment in accord with stratified result of the established model.",[13],"Procedure: Model-guided adjuvant treatment",{"label":15,"type":10,"description":16,"interventionNames":17},"non-model-stratified group","Patient receiving treatment not in accord with stratified result of the established model.",[18],"Procedure: No adjuvant treatment",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"PROCEDURE","Model-guided adjuvant treatment","Initiation of standard adjuvant treatment within 12 weeks after surgery.",[9],{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"No adjuvant treatment","No initiation of adjuvant ICIs, radiotherapy, or targeted therapy at any point during follow-up prior to disease progression.",[15],[30,34],{"name":31,"affiliation":32,"role":33},"Yongyue Wei, master","Peking University Health Science Center","STUDY_DIRECTOR",{"name":35,"affiliation":5,"role":36},"Shudong Zhang, master","PRINCIPAL_INVESTIGATOR",[38],{"name":39,"role":40,"phone":41,"phoneExt":10,"email":42},"Jiyuan Chen, master","CONTACT","+086 18801430995","chenjiyuan@pku.edu.cn",[44],{"facility":5,"status":45,"city":46,"state":47,"zip":48,"country":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","Beijing","Beijing Municipality","100191","China",{"type":51,"coordinates":52},"Point",[53,54],116.39723,39.9075,{"lat":54,"lon":53},[57],{"name":39,"role":40,"phone":41,"phoneExt":10,"email":42},{"type":59,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100601955",false,"NCT07117227","Validation of RCC Predicting Model With Emulated-target Trial","Emulated-target Trial for Guiding Stratified Treatment for Renal Cell Carcinoma With Venous Tumor Thrombus","RCCETT","Inclusion Criteria:\n\n* Adults ≥18 years of age;\n* Diagnosis of primary renal cell carcinoma before and during the surgery;\n* Received radical nephrectomy\u002Fnephron-sparing surgery.\n\nExclusion Criteria:\n\n* Subjects with severely missing clinical information;\n* History of other malignant tumors.\n* Recurrence observed before first postoperative follow-up.\n* Discontinue the adjuvant treatment within in the first two course because of severe adverse react.","ALL","18 Years","80 Years",{"count":71,"type":72},4700,"ESTIMATED","2 Years","OBSERVATIONAL","This single-center study utilizes real-world data (2012-2024) from 4700 renal cell carcinoma (RCC) patients at Peking University Third Hospital to: (1) Develop and validate a prognostic prediction model specifically for RCC patients, including those with venous tumor thrombus (VTT); (2) Compare the performance of this new model against existing RCC prediction models in both the overall RCC cohort and the VTT subgroup; (3) Employ an emulated target trial (ETT) methodology to evaluate whether risk-stratified treatment based on the prediction model (grouping patients as high\u002Fmedium\u002Flow risk) improves survival outcomes .",[77,78,79,80,81,82,83],"Renal Cell Carcinoma (Kidney Cancer)","Renal Cell Carcinoma (RCC)","Tumor Thrombus","Prognosis","Prognostic Cancer Model","Real World Study","Observational Study",[85,86,87,88],"renal cell carcinoma","tumor thrombus","prognostic model","emulated-target trial","2026-04-08",{"date":91,"type":92},"2026-04-14","ACTUAL",{"date":94,"type":92},"2025-09-01",{"date":96,"type":72},"2027-08-01",{"name":5,"class":6},1]